Author

P. Erler

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

E. Barbieux· 1 shared E. Guillen· 1 shared G. Lauvau· 1 shared K. Nishitani· 1 shared M. Boutet· 1 shared M. Suzuki· 1 shared N. Couturier· 1 shared W. Guo· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

E. Barbieux

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The MLL3/TP53/PIK3CA cancer driver mutations promote HIF1alpha-dependent recruitment and differentiation of pro-tumor ICOShiGITRhi Blimp-1+ effector regulatory T cells in breast tumors

M. Boutet, K. Nishitani, P. Erler, N. Couturier, Z. Zhang, E. Barbieux, E. Guillen, M. Suzuki, W. Guo, G. Lauvau

This study shows that MLL3/TP53/PIK3CA mutations in breast tumors promote immunosuppressive Treg cell differentiation via HIF1alpha, leading to tumor growth and suggesting therapeutic targets.

bioRxiv · Oct 2, 2022 · PreprintImmunology